Here are detailed answers to all five pathology questions, sourced from Robbins, Cotran & Kumar - Pathologic Basis of Disease.
Que 1: Differentiate Reversible and Irreversible Cell Injury with Ultrastructural Changes
Reversible Cell Injury
Reversible injury represents early or mild forms of injury that are correctable if the damaging stimulus is removed. The cell can repair the alterations and return to normalcy.
Light Microscopic / Gross Changes:
- Cellular swelling (earliest manifestation) - caused by failure of the ATP-dependent Na+/K+ pump, leading to influx of water
- Hydropic change / vacuolar degeneration - small clear vacuoles representing distended segments of ER
- Cytoplasm appears more eosinophilic (loss of RNA which normally binds hematoxylin)
- Fatty change - in organs like the liver involved in lipid metabolism
Ultrastructural Changes (by Electron Microscopy):
- Plasma membrane alterations - blebbing, blunting, and loss of microvilli
- Mitochondrial changes - swelling and appearance of small amorphous densities
- Accumulation of "myelin figures" in the cytosol (phospholipids from damaged membranes)
- Dilation of the ER with detachment of polysomes (ribosomes)
- Nuclear alterations - disaggregation of granular and fibrillar elements
Irreversible Cell Injury (Necrosis)
Irreversible injury occurs when the injurious stimulus persists and cells pass the "point of no return." It is characterized by severe mitochondrial damage, ATP depletion, and rupture of lysosomal and plasma membranes.
Light Microscopic Changes:
- Nuclear changes: Pyknosis (nuclear shrinkage and dark staining), Karyorrhexis (nuclear fragmentation), Karyolysis (nuclear dissolution by DNases)
- Cytoplasm becomes deeply eosinophilic
- Loss of cellular outlines in advanced necrosis
Ultrastructural Changes:
- Membrane disruption - severe plasma membrane damage with leakage of cellular contents
- Markedly swollen mitochondria containing electron-dense deposits (precipitated calcium and proteins) - this is the hallmark of irreversibility
- Myelin figures - derived from damaged membranes
- Flocculent amorphous densities in mitochondria
- Nuclear fragmentation and dissolution
- Lysosomal rupture with release of digestive enzymes into cytoplasm
Key Differentiating Point: Irreversibility is marked by (1) severe mitochondrial dysfunction with dense amorphous deposits, and (2) profound disturbances in membrane function.
| Feature | Reversible | Irreversible |
|---|
| Mitochondria | Swelling, small amorphous densities | Markedly swollen, large dense deposits (Ca2+ & protein) |
| Plasma membrane | Blebs, blunted microvilli | Disrupted, leaking contents |
| ER | Dilated, ribosomes detached | Markedly disrupted |
| Nucleus | Chromatin clumping | Pyknosis, karyorrhexis, karyolysis |
| Lysosomes | Intact | Ruptured |
| Outcome | Reversible if stimulus removed | Cell death inevitable |
Source: Robbins, Cotran & Kumar - Pathologic Basis of Disease, Fig. 2.9
Que 2: Mechanism of Ischemic Reperfusion Injury
Ischemia-reperfusion injury is paradoxical: restoring blood flow to ischemic tissue can worsen cell damage rather than simply reversing it. This occurs through several interconnected mechanisms:
1. Oxidative Stress (Reactive Oxygen Species - ROS)
- When blood flow is restored, the sudden burst of oxygen in previously ischemic tissue leads to massive generation of ROS (superoxide, hydrogen peroxide, hydroxyl radicals)
- Ischemic cells have reduced antioxidant defenses (depleted glutathione, SOD)
- ROS attack lipid membranes (lipid peroxidation), proteins, and DNA, causing further membrane damage
- Activated neutrophils (recruited during reperfusion) generate additional ROS via respiratory burst
2. Calcium Overload
- Ischemia depletes ATP, causing failure of the Na+/Ca2+ exchanger and Ca2+ ATPase
- During reperfusion, Ca2+ floods into cells
- Excess intracellular Ca2+ activates:
- Phospholipases (membrane damage)
- Proteases (cytoskeletal disruption)
- ATPases (further ATP depletion)
- Endonucleases (DNA damage)
- Ca2+ also accumulates in mitochondria, inducing the mitochondrial permeability transition (MPT)
3. Mitochondrial Permeability Transition (MPT)
- During reperfusion, the sudden influx of Ca2+ and ROS triggers opening of the MPT pore in the inner mitochondrial membrane
- This allows passage of molecules <1.5 kDa into the mitochondrial matrix
- Mitochondrial membrane potential collapses, ATP synthesis stops
- Cytochrome c is released - triggering apoptosis
- Mitochondria swell and rupture - causing necrosis
4. Neutrophil Activation and Inflammation
- Ischemic tissue produces cytokines (IL-1, TNF) and complement fragments that attract neutrophils during reperfusion
- Neutrophils adhere to activated endothelium (which upregulates selectins and ICAM-1 during ischemia)
- Activated neutrophils release:
- ROS
- Proteases (elastase, collagenase)
- Myeloperoxidase
- This amplifies cell injury far beyond the original ischemic zone
5. Complement Activation
- Ischemic tissue activates complement via the alternative and lectin pathways
- Complement fragments (C3a, C5a) attract more neutrophils and cause direct membrane damage via the membrane attack complex (MAC)
Summary Diagram
Ischemia → ATP depletion → Na+/K+ pump failure → cell swelling, Ca2+ influx
↓
Reperfusion → Burst of O2 → ROS + Neutrophil recruitment → Membrane damage → MPT pore opening → Cytochrome c release → Apoptosis/Necrosis
Que 3: Compare Apoptosis and Necrosis with Examples
Definition
- Necrosis: Pathologic cell death due to severe injury, characterized by enzymatic digestion and protein denaturation of the cell
- Apoptosis: Regulated (programmed) cell death mediated by specific molecular pathways, executed with "surgical precision"
Comparison Table
| Feature | Necrosis | Apoptosis |
|---|
| Nature | Pathological (accidental) | Physiological or pathological |
| Cause | Ischemia, toxins, infections, trauma | Growth factor withdrawal, DNA damage, physiologic signals |
| Cell size | Enlarged (swelling) | Reduced (shrinkage) |
| Nucleus | Pyknosis → Karyorrhexis → Karyolysis | Fragmentation into nucleosome-size fragments |
| Plasma membrane | Disrupted, cell lyses | Intact; altered lipid orientation (phosphatidylserine exposed) |
| Cellular contents | Enzymatic digestion, leaks out | Intact; released in apoptotic bodies |
| Inflammation | Frequent (DAMPs trigger it) | No - phagocytes clear bodies quietly |
| Mechanism | Passive - failure of ion pumps, membrane damage | Active - caspase cascade (intrinsic/extrinsic pathways) |
| ATP required | Not required (passive) | Required (active process) |
| Physiologic role | None - always pathological | Normal development, immune regulation, removal of damaged cells |
Mechanisms of Apoptosis
Intrinsic (Mitochondrial) Pathway:
- Triggered by DNA damage, oxidative stress, growth factor withdrawal
- Pro-apoptotic proteins (BAX, BAK) are activated and insert into mitochondrial membrane
- Anti-apoptotic proteins BCL-2 and BCL-XL are inhibited
- Cytochrome c is released from mitochondria
- Cytochrome c + APAF-1 → Apoptosome → Activates Caspase-9 → Caspase-3 → Cell death
Extrinsic (Death Receptor) Pathway:
- FasL binds to Fas (CD95) receptor on target cell
- FADD adaptor protein recruited to Fas
- Pro-caspase-8 binds FADD → Auto-cleaved → Active Caspase-8 → Caspase-3 cascade
Examples
| Necrosis Type | Example |
|---|
| Coagulative | Myocardial infarction, kidney infarct |
| Liquefactive | Brain infarct, bacterial abscess |
| Caseous | Tuberculosis of lung |
| Fat necrosis | Acute pancreatitis |
| Gangrenous | Diabetic limb ischemia |
| Apoptosis | Example |
|---|
| Physiologic | Embryonic development (web removal between fingers), endometrial shedding, thymic deletion of self-reactive T cells |
| Pathologic | HIV-infected T cell depletion, liver cell death in viral hepatitis, neuron death in Alzheimer disease, radiation-induced cell death |
Que 4: Classify Amyloidosis and Pathogenesis of AL and AA
What is Amyloidosis?
Amyloidosis is a group of diseases characterized by extracellular deposition of abnormally folded proteins that form insoluble fibrils. Misfolded proteins escape normal proteasomal and macrophage degradation and deposit in tissues, causing organ dysfunction through abnormal tissue architecture.
Classification (Table 6.17 - Robbins Pathology)
Systemic (Generalized) Amyloidosis
| Type | Associated Disease | Fibril Protein | Precursor Protein |
|---|
| AL (Amyloid Light Chain) | Multiple myeloma, Monoclonal gammopathy | AL (κ or λ light chains) | Ig light chains |
| AA (Amyloid A) | Chronic inflammatory diseases (RA, IBD, TB, bronchiectasis) | AA protein | Serum Amyloid A (SAA) |
| ATTR (Transthyretin) | Familial cardiomyopathy, polyneuropathy; Senile systemic | ATTR | Transthyretin (TTR) |
Localized Amyloidosis
- Deposits limited to a single organ
- Sites: lung, larynx, skin, bladder, tongue, eye
- Also: Endocrine amyloid in medullary thyroid carcinoma, type 2 DM islets (IAPP)
Other Forms
- Hemodialysis-associated amyloidosis - β2-microglobulin deposits in joints/carpal tunnel
- Familial Mediterranean Fever (FMF) - AA type; autosomal recessive, pyrin mutation → excess IL-1 → excess SAA production
Pathogenesis of AL Amyloidosis
- A clonal plasma cell proliferation (in multiple myeloma or monoclonal gammopathy) synthesizes abnormal amounts of a single immunoglobulin (Ig)
- Malignant plasma cells secrete free, unpaired κ or λ light chains (Bence-Jones proteins) into serum and urine
- These light chains have specific amino acid sequences that confer amyloidogenic potential - they are intrinsically prone to misfolding
- Misfolded light chains aggregate into beta-pleated sheet fibrils that are resistant to degradation
- Fibrils deposit extracellularly in tissues (kidney, heart, liver, nerves) causing organ dysfunction
- Most patients with AL amyloid have underlying monoclonal gammopathy even without overt myeloma
Key point: The most common form of systemic amyloidosis (~2000-3000 cases/year in USA), always caused by plasma cell clones, even when no obvious myeloma exists.
Pathogenesis of AA Amyloidosis
- Triggered by chronic inflammatory conditions (rheumatoid arthritis, ankylosing spondylitis, IBD, chronic infections like TB, osteomyelitis)
- Chronic inflammation causes prolonged production of cytokines IL-6 and IL-1 by macrophages
- These cytokines stimulate the liver to synthesize large amounts of SAA (Serum Amyloid A), an acute phase protein
- Normally, SAA is degraded by macrophage-derived enzymes to soluble end products
- In amyloidosis patients, incomplete degradation of SAA occurs - likely due to:
- Enzyme defects in macrophages
- Structurally abnormal SAA molecules resistant to degradation
- Insoluble AA protein fragments accumulate and deposit systemically (particularly in kidney, spleen, liver, adrenal glands)
- Most common associated condition: Rheumatoid arthritis (amyloidosis in ~3% of RA patients)
Que 5: Mechanism of Intracellular Accumulation
Intracellular accumulations occur when a cell acquires abnormal amounts of various substances, due to metabolic derangements. The substances are either normal or abnormal, endogenous or exogenous.
Four Mechanisms of Intracellular Accumulation
1. Inadequate Removal of Normal Substance
- The cell produces a normal substance at normal rate but the metabolic pathway is defective and the substance cannot be removed
- Examples:
- Fatty liver (hepatic steatosis): Normal triglycerides cannot be exported as VLDL (due to protein deficiency, toxins like alcohol, malnutrition). Lipid vacuoles accumulate in hepatocytes
- Cholesterol accumulation in foam cells: In atherosclerosis, macrophages engulf oxidized LDL but cannot export cholesterol efficiently
2. Normal or Abnormal Endogenous Substance - Defective Metabolism (Enzyme Defect)
- A genetic defect in an enzyme causes failure to metabolize a normal substrate
- Substrate accumulates within cells (lysosomes)
- Examples:
- Lysosomal storage diseases (e.g., Gaucher disease - failure to degrade glucocerebroside; Niemann-Pick disease - sphingomyelin accumulation; Tay-Sachs - GM2 ganglioside accumulation)
- α1-antitrypsin deficiency - abnormal protein accumulates in hepatocyte ER (not in lysosomes)
3. Abnormal Endogenous Substance - Cannot Be Degraded
- Mutant proteins that are abnormally folded cannot be degraded by proteasomes and accumulate intracellularly
- Examples:
- Mallory bodies (alcoholic hyalin) - cytokeratin intermediate filaments in hepatocytes of alcoholics
- Neurofibrillary tangles in Alzheimer disease (hyperphosphorylated tau protein)
- Lewy bodies in Parkinson disease (α-synuclein accumulation)
4. Exogenous Substance Deposited and Cannot Be Degraded
- A substance is ingested but the cell lacks machinery to degrade it
- Examples:
- Carbon particles in macrophages (coal workers' pneumoconiosis / anthracosis) - carbon ingested by alveolar macrophages, accumulates as blackened deposits in lung
- Silica particles in silicosis
- Hemosiderin - after repeated red cell breakdown, iron-laden macrophages in tissues
Summary Table
| Mechanism | Substance | Example |
|---|
| Defective metabolism/export | Triglycerides | Fatty liver (alcohol, malnutrition) |
| Enzyme defect → substrate buildup | Sphingolipids, glucocerebroside | Lysosomal storage diseases |
| Abnormal protein, not degraded | Mutant/misfolded proteins | Mallory bodies, Lewy bodies, neurofibrillary tangles |
| Exogenous, not degradable | Carbon, silica, iron | Anthracosis, silicosis, hemosiderosis |
All answers sourced from: Robbins, Cotran & Kumar - Pathologic Basis of Disease (Robbins Pathology)